First Time Loading...

Biosig Technologies Inc
NASDAQ:BSGM

Watchlist Manager
Biosig Technologies Inc Logo
Biosig Technologies Inc
NASDAQ:BSGM
Watchlist
Price: 1.555 USD 10.28% Market Closed
Updated: Apr 23, 2024

Intrinsic Value

BSGM's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

BioSig Technologies, Inc. is a medical technology company, which engages in the development of a proprietary biomedical signal processing platform designed to improve signal fidelity and uncover the f... [ Read More ]

The intrinsic value of one BSGM stock under the Base Case scenario is 1.533 USD. Compared to the current market price of 1.555 USD, Biosig Technologies Inc is Overvalued by 1%.

Key Points:
BSGM Intrinsic Value
Base Case
1.533 USD
Overvaluation 1%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Biosig Technologies Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling BSGM stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
Biosig Technologies Inc

Provide an overview of the primary business activities
of Biosig Technologies Inc.

What unique competitive advantages
does Biosig Technologies Inc hold over its rivals?

What risks and challenges
does Biosig Technologies Inc face in the near future?

Has there been any significant insider trading activity
in Biosig Technologies Inc recently?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Biosig Technologies Inc.

Provide P/S
for Biosig Technologies Inc.

Provide P/E
for Biosig Technologies Inc.

Provide P/OCF
for Biosig Technologies Inc.

Provide P/FCFE
for Biosig Technologies Inc.

Provide P/B
for Biosig Technologies Inc.

Provide EV/S
for Biosig Technologies Inc.

Provide EV/GP
for Biosig Technologies Inc.

Provide EV/EBITDA
for Biosig Technologies Inc.

Provide EV/EBIT
for Biosig Technologies Inc.

Provide EV/OCF
for Biosig Technologies Inc.

Provide EV/FCFF
for Biosig Technologies Inc.

Provide EV/IC
for Biosig Technologies Inc.

Show me price targets
for Biosig Technologies Inc made by professional analysts.

What are the Revenue projections
for Biosig Technologies Inc?

How accurate were the past Revenue estimates
for Biosig Technologies Inc?

What are the Net Income projections
for Biosig Technologies Inc?

How accurate were the past Net Income estimates
for Biosig Technologies Inc?

What are the EPS projections
for Biosig Technologies Inc?

How accurate were the past EPS estimates
for Biosig Technologies Inc?

What are the EBIT projections
for Biosig Technologies Inc?

How accurate were the past EBIT estimates
for Biosig Technologies Inc?

Compare the revenue forecasts
for Biosig Technologies Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Biosig Technologies Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Biosig Technologies Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Biosig Technologies Inc compared to its peers.

Compare the P/E ratios
of Biosig Technologies Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Biosig Technologies Inc with its peers.

Analyze the financial leverage
of Biosig Technologies Inc compared to its main competitors.

Show all profitability ratios
for Biosig Technologies Inc.

Provide ROE
for Biosig Technologies Inc.

Provide ROA
for Biosig Technologies Inc.

Provide ROIC
for Biosig Technologies Inc.

Provide ROCE
for Biosig Technologies Inc.

Provide Gross Margin
for Biosig Technologies Inc.

Provide Operating Margin
for Biosig Technologies Inc.

Provide Net Margin
for Biosig Technologies Inc.

Provide FCF Margin
for Biosig Technologies Inc.

Show all solvency ratios
for Biosig Technologies Inc.

Provide D/E Ratio
for Biosig Technologies Inc.

Provide D/A Ratio
for Biosig Technologies Inc.

Provide Interest Coverage Ratio
for Biosig Technologies Inc.

Provide Altman Z-Score Ratio
for Biosig Technologies Inc.

Provide Quick Ratio
for Biosig Technologies Inc.

Provide Current Ratio
for Biosig Technologies Inc.

Provide Cash Ratio
for Biosig Technologies Inc.

What is the historical Revenue growth
over the last 5 years for Biosig Technologies Inc?

What is the historical Net Income growth
over the last 5 years for Biosig Technologies Inc?

What is the current Free Cash Flow
of Biosig Technologies Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for Biosig Technologies Inc.

Financials

Balance Sheet Decomposition
Biosig Technologies Inc

Current Assets 1.1m
Cash & Short-Term Investments 490k
Receivables 10k
Other Current Assets 550k
Non-Current Assets 2.1m
Long-Term Investments 40k
PP&E 1.1m
Intangibles 290k
Other Non-Current Assets 690k
Current Liabilities 3.9m
Accrued Liabilities 3.8m
Other Current Liabilities 100k
Non-Current Liabilities 300k
Other Non-Current Liabilities 300k
Efficiency

Earnings Waterfall
Biosig Technologies Inc

Revenue
150k USD
Cost of Revenue
-40k USD
Gross Profit
110k USD
Operating Expenses
-29.5m USD
Operating Income
-29.4m USD
Other Expenses
-700k USD
Net Income
-30.1m USD

Free Cash Flow Analysis
Biosig Technologies Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
What is Free Cash Flow?
Fundamental Scores

BSGM Profitability Score
Profitability Due Diligence

Biosig Technologies Inc's profitability score is 25/100. The higher the profitability score, the more profitable the company is.

Exceptional Revenue Growth Forecast
Positive Gross Profit
ROIC is Increasing
Negative 1-Year Revenue Growth
25/100
Profitability
Score

Biosig Technologies Inc's profitability score is 25/100. The higher the profitability score, the more profitable the company is.

BSGM Solvency Score
Solvency Due Diligence

Biosig Technologies Inc's solvency score is 40/100. The higher the solvency score, the more solvent the company is.

Low D/E
Long-Term Solvency
Short-Term Solvency
Low Altman Z-Score
40/100
Solvency
Score

Biosig Technologies Inc's solvency score is 40/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

BSGM Price Targets Summary
Biosig Technologies Inc

There are no price targets for BSGM.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Ownership

BSGM Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Shareholder Return

BSGM Price
Biosig Technologies Inc

1M 1M
+183%
6M 6M
+188%
1Y 1Y
+13%
3Y 3Y
-59%
5Y 5Y
-76%
10Y 10Y
-81%
Annual Price Range
1.555
52w Low
0.1681
52w High
2.01
Price Metrics
Average Annual Return -40.82%
Standard Deviation of Annual Returns 31.44%
Max Drawdown -99%
Shares Statistics
Market Capitalization 14.5m USD
Shares Outstanding 9 334 640
Percentage of Shares Shorted 8.9%

BSGM Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

Biosig Technologies Inc Logo
Biosig Technologies Inc

Country

United States of America

Industry

Health Care

Market Cap

14.5m USD

Dividend Yield

0%

Description

BioSig Technologies, Inc. is a medical technology company, which engages in the development of a proprietary biomedical signal processing platform designed to improve signal fidelity and uncover the full range of electrocardiographic and intra-cardiac signals. The company is headquartered in Westport, Connecticut and currently employs 50 full-time employees. The company went IPO on 2014-09-22. The firm is focused on providing intracardiac signal information to electrophysiologists during electrophysiology (EP) studies and cardiac catheter ablation procedures for atrial fibrillation (AF) and ventricular tachycardia (VT). The firm is commercializing its PURE EP System, which is designed to address long-standing limitations that slow and disrupt cardiac catheter ablation procedures, such as environmental lab noise, signal saturation, slow signal recovery, and inaccurate display of fractionated potentials. PURE EP is a signal processing platform that combines hardware and software to address known challenges associated with signal acquisition, to enable electrophysiologists to see more signals and analyze them in real-time. The device aims to minimize noise and artifacts from cardiac recordings and acquire high-fidelity cardiac signals.

Contact

CONNECTICUT
Westport
55 Greens Farms Road
+12034095444.0
https://www.biosig.com/

IPO

2014-09-22

Employees

50

Officers

President, Principal Executive Officer & Executive VP
Mr. Frederick D. Hrkac
Chief Scientist
Dr. Budimir S. Drakulic Ph.D.
Vice President of Investor Relations
Mr. Andrew Gornell Ballou

See Also

Discover More
What is the Intrinsic Value of one BSGM stock?

The intrinsic value of one BSGM stock under the Base Case scenario is 1.533 USD.

Is BSGM stock undervalued or overvalued?

Compared to the current market price of 1.555 USD, Biosig Technologies Inc is Overvalued by 1%.